[Objective]To summarize Professor QIN Danping's experience in applying traditional Chinese medicine to treat intestinal graft-versus-host disease.[Methods]Through following Professor QIN's outpatient service,collecting and sorting out medical cases,the academic characteristics of Professor QIN in treatment of intestinal graft-versus-host disease were summarized from the aspects of disease cognition,syndrome evolution and clinical treatment,and the medical cases were attached to support it.[Results]It is believed that the patient of transplant is the subject,the transplanted allogeneic hematopoietic stem cells are the objects and spleen deficiency is the basis.After transplantation,the object enter the body to produce dampness,heat,cold,stasis and toxin,which act on the intestine to cause disease.The pathogenesis of the disease is root deficiency and branch excess.Treatment emphasizes both symptoms and root causes,invigorating the spleen and supplementing Qi is basic treatment principle,dispelling dampness,regulating cold and heat,regulating Qi and dissolving stasis are manifestations,to make the vital Qi and evil Qi mutually inclusive and the disease achieve stable.The medical cases mentioned were acute gastrointestinal graft-versus-host disease and chronic intestinal graft-versus-host disease,were treated by strengthening the spleen and clearing dampness-heat,harmonizing stomach and stopping diarrhea,regulating cold and heat,strengthening the spleen to control diarrhea separately,and both cases achieved significant effect.[Conclusion]Professor QIN aims at making the ontology and foreign body mutually inclusive,adopts"strengthening the body resistance and resolving pathogen"as the core in the treatment of intestinal graft-versus-host disease,improves clinical symptoms and alleviates the intestinal mucosal inflammation,which is worth further exploration.

Objective:To further improve the understanding of paroxysmal nocturnal hemoglobinuria (PNH), we retrospectively analyzed and summarized the clinical characteristics, treatment status, and survival status of patients with PNH in Zhejiang Province.Methods:This study included 289 patients with PNH who visited 20 hospitals in Zhejiang Province. Their clinical characteristics, comorbidity, laboratory test results, and medications were analyzed and summarized.Results:Among the 289 patients with PNH, 148 males and 141 females, with a median onset age of 45 (16-87) years and a peak onset age of 20-49 years (57.8% ). The median lactic dehydrogenase (LDH) level was 1 142 (604-1 925) U/L. Classified by type, 70.9% (166/234) were classical, 24.4% (57/234) were PNH/bone marrow failure (BMF), and 4.7% (11/234) were subclinical. The main clinical manifestations included fatigue or weakness (80.8%, 235/289), dizziness (73.4%, 212/289), darkened urine color (66.2%, 179/272), and jaundice (46.2%, 126/270). Common comorbidities were hemoglobinuria (58.7% ), renal dysfunction (17.6% ), and thrombosis (15.0% ). Moreover, 82.3% of the patients received glucocorticoid therapy, 70.9% required blood transfusion, 30.7% used immunosuppressive agents, 13.8% received anticoagulant therapy, and 6.3% received allogeneic hematopoietic stem cell transplantation. The 10-year overall survival (OS) rate was 84.4% (95% CI 78.0% -91.3% ) . Conclusion:Patients with PNH are more common in young and middle-aged people, with a similar incidence rate between men and women. Common clinical manifestations include fatigue, hemoglobinuria, jaundice, renal dysfunction, and recurrent thrombosis. The 10-year OS of this group is similar to reports from other centers in China.

OBJECTIVE: The study aimed to investigate the efficacy and adverse effects of sublingual immunotherapy (SLIT) of dust mite drops to allergic rhinitis with mite allergy. The compliance and satisfaction of SLIT were also assessed. METHOD: One hundred and three patients of allergic rhinitis sensitive to dust mites were treated with SLIT for 6 months or more. The symptom questionnaire,including items on rhinorrhea, sneezing, nasal obstruction, itchy nose, olfactory disturbance, eye discomfort and sleep disturbance were obtained before and 6 months after SLIT. The patients' satisfaction and adverse effects were also investigated. RESULT: Seventy-five of the 103 patients insist on SLIT for more than 6 months and completed the questionnaire. The duration of receiving SLIT was 9.8 months on average (range from 6 to 13 months). The satisfaction rate was 89.3%. The drop-out rate of SLIT was 31.0%. CONCLUSION The subjective symptoms were improved with SLIT in patients with allergic rhinitis sensitive to dust mites. The drop out rate was high despite of the symptomatic improvement.
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Female ; Humans ; Male ; Middle Aged ; Patient Compliance ; Patient Satisfaction ; Rhinitis, Allergic ; Rhinitis, Allergic, Perennial ; psychology ; therapy ; Sublingual Immunotherapy ; psychology ; Treatment Outcome ; Young Adult

Aged ; Aged, 80 and over ; Cytarabine ; administration & dosage ; therapeutic use ; Female ; Harringtonines ; administration & dosage ; therapeutic use ; Humans ; Induction Chemotherapy ; methods ; Leukemia, Myeloid, Acute ; drug therapy ; Male ; Middle Aged

Ablation Techniques ; adverse effects ; methods ; Humans ; Lung Neoplasms ; diagnostic imaging ; radiotherapy ; surgery ; Postoperative Complications ; prevention & control ; therapy ; Radio Waves ; therapeutic use ; Radiotherapy, Image-Guided ; adverse effects ; methods ; Treatment Outcome

"The Expert Group on Tumor Ablation Therapy of Chinese Medical Doctor Association, The Tumor Ablation Committee of Chinese College of Interventionalists, The Society of Tumor Ablation Therapy of Chinese Anti-Cancer Association and The Ablation Expert Committee of the Chinese Society of Clinical Oncology" have organized multidisciplinary experts to formulate the consensus for thermal ablation of pulmonary subsolid nodules or ground-glass nodule (GGN). The expert consensus reviews current literatures and provides clinical practices for thermal ablation of GGN. The main contents include: (1) clinical evaluation of GGN, (2) procedures, indications, contraindications, outcomes evaluation and related complications of thermal ablation for GGN and (3) future development directions.
.